Tempest Therapeutics Inc
(TPST)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 0 | 0 | 653 | 277 |
| Cost of Goods | N/A | N/A | N/A | 5,401 | 2,249 |
| Gross Profit | N/A | N/A | N/A | -4,748 | -1,972 |
| Operating Expenses | 45,399 | 26,874 | 84,326 | 76,665 | 70,276 |
| Operating Income | -45,399 | -26,874 | -84,326 | -81,012 | -71,999 |
| Interest Expense | 0 | 134 | 288 | 0 | 0 |
| Other Income | 831 | -169 | 28 | -1,047 | -1,145 |
| Pre-tax Income | -44,568 | -27,177 | -84,586 | -82,059 | -73,144 |
| Income Tax | N/A | N/A | N/A | 201 | 75 |
| Net Income Continuous | -44,568 | -27,177 | -84,586 | -82,260 | -73,219 |
| Minority Interests | N/A | 15 | -8 | N/A | N/A |
| Net Income | $-44,568 | $-27,192 | $-84,578 | $-82,260 | $-73,219 |
| EPS Basic Total Ops | -633.62 | -3,427.42 | -62,740.41 | -7,482.76 | -7,891.98 |
| EPS Basic Continuous Ops | -633.91 | -3,424.99 | -62,703.32 | -7,479.23 | -7,901.64 |
| EPS Diluted Total Ops | -633.62 | -3,427.42 | -62,740.41 | -7,482.76 | -7,891.98 |
| EPS Diluted Continuous Ops | -633.91 | -3,424.99 | -62,703.32 | -7,479.23 | -7,901.64 |
| EPS Diluted Before Non-Recurring Items | -633.62 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-44,347 | $-26,842 | $-84,298 | $-78,115 | $-69,597 |